In our patient population meeting genetic test criteria for HBOC or Lynch syndrome, 12.5% of patients were found to have a pathogenic mutation, with the most common being in BRCA1/2 followed by MUTYH and CHEK2. This evidence concerns the gene CHEK2 and Lynch syndrome.